ALACHUA, FL--(Marketwire - March 03, 2008) - Oragenics, Inc. (AMEX: ONI), a biotechnology company focused primarily on infectious diseases, announced today that a total of 3,386,364 warrants issued to investors who participated in the August 2007 investment round in Oragenics have been exercised early at a price of $0.44. This early exercise resulted in aggregate proceeds to the Company of $1.49 million. The Company plans to use the proceeds of this warrant exercise to support its lead product development programs.
